Hologic Inc (BSP:H1OL34)
R$ 447.04 0 (0%) Market Cap: 101.45 Bil Enterprise Value: 103.43 Bil PE Ratio: 22.62 PB Ratio: 3.40 GF Score: 86/100

Hologic Inc at Bank of America Merrill Lynch Healthcare Conference (Virtual) Transcript

May 12, 2020 / 08:20PM GMT
Release Date Price: R$208.7
Xiaoxiao Ma
BofA Merrill Lynch, Research Division - Associate

Good afternoon, and welcome to the Bank of America 2020 Healthcare Conference. This is Ivy Ma, Diagnostic Analyst here at BofA. I'm pleased to be joined by Hologic's CFO, Karleen Oberton; as well as Head of Investor Relations, Mike Watts. Thank you so much for joining us today.

We have a pretty ambitious agenda today, and we'll try to take some investor questions from the webcast. So I'll turn it over to Karleen. I think you have some quick intro remarks to kick it off. Thanks.

Karleen M. Oberton
Hologic, Inc. - CFO

Thanks, Ivy. And thanks for hosting us on the call today. So let me just start about Hologic a little bit, it is a global medical device company; and one of our hallmarks is market leading, clinically differentiated products, including our Panther fully automated high-through instrumentation for molecular diagnostics testing. And while there is a lot of uncertainty in the world right now, we know 2 things. First, our business was performing very well pre-COVID with 5.2% growth

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot